Predicate |
Object |
contentType |
Journal Article |
endingPage |
702 |
issn |
1948-5875 |
issueIdentifier |
5 |
pageRange |
701-702 |
publicationName |
ACS Medicinal Chemistry Letters |
startingPage |
701 |
bibliographicCitation |
Kargbo RB. Treatment of Prostate Cancers and Kennedy’s Disease by PROTAC-Androgen Receptor Degradation. ACS Med. Chem. Lett. 2019 Apr 01;10(5):701–2. doi: 10.1021/acsmedchemlett.9b00115. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5539-6343 |
date |
2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC6512008 https://doi.org/10.1021/acsmedchemlett.9b00115 https://pubmed.ncbi.nlm.nih.gov/31097985 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 https://portal.issn.org/resource/ISSN/1948-5875 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Treatment of Prostate Cancers and Kennedy’s Disease by PROTAC-Androgen Receptor Degradation |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11120 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 |